These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16514819)

  • 21. Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance.
    Topcu S; Tok D; Caliskan M; Ozcimen EE; Gullu H; Uckuyu A; Erdogan D; Zeyneloglu H; Muderrisoglu H
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):75-80. PubMed ID: 16817823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
    Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW; Kilpatrick ES; Keevil BG; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin increases insulin sensitivity and plasma beta-endorphin in human subjects.
    Ou HY; Cheng JT; Yu EH; Wu TJ
    Horm Metab Res; 2006 Feb; 38(2):106-11. PubMed ID: 16523411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
    Umpierrez G; Issa M; Vlajnic A
    Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial.
    Nair S; Diehl AM; Wiseman M; Farr GH; Perrillo RP
    Aliment Pharmacol Ther; 2004 Jul; 20(1):23-8. PubMed ID: 15225167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
    Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
    Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzbromarone therapy in management of refractory gout.
    Kumar S; Ng J; Gow P
    N Z Med J; 2005 Jun; 118(1217):U1528. PubMed ID: 15980902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.
    Schumacher HR; Becker MA; Lloyd E; MacDonald PA; Lademacher C
    Rheumatology (Oxford); 2009 Feb; 48(2):188-94. PubMed ID: 19141576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus.
    Salpeter SR; Buckley NS; Kahn JA; Salpeter EE
    Am J Med; 2008 Feb; 121(2):149-157.e2. PubMed ID: 18261504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.
    Dastjerdi MS; Kazemi F; Najafian A; Mohammady M; Aminorroaya A; Amini M
    Int J Obes (Lond); 2007 Apr; 31(4):713-7. PubMed ID: 16969361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The uric acid-lowering effect of diflunisal].
    Fasching U
    Wien Klin Wochenschr; 1987 Nov; 99(22):791-3. PubMed ID: 3433782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary studies with azapropazone in gout and hyperuricaemia.
    Thomas AL; Majoos FL; Nuki G
    Eur J Rheumatol Inflamm; 1983; 6(2):149-54. PubMed ID: 6673978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arresting an acute attack of gout. Open pilot study in 98 patients].
    Bodem H
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):203-6. PubMed ID: 3872833
    [No Abstract]   [Full Text] [Related]  

  • 37. [Rehabilitation of patients with gout during outpatient follow-up].
    Ivanova MM; Novoselova TM; Akimova TF; Tsurko VV
    Ter Arkh; 1987; 59(4):28-31. PubMed ID: 3590000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gout: an experience from Zimbabwe.
    Lutalo SK
    Cent Afr J Med; 1993 Mar; 39(3):60-2. PubMed ID: 8306386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions.
    Gheita TA; El-Fishawy HS; Nasrallah MM; Hussein H
    Int J Rheum Dis; 2012 Dec; 15(6):521-5. PubMed ID: 23253234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of acute gout attacks with tolmetin (author's transl)].
    Petera P; Gaismayer K; Tausch G
    Wien Med Wochenschr; 1982 Jan; 132(2):43-5. PubMed ID: 7072257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.